Morepen Laboratories Limited has informed the Exchange regarding a press release dated December 03, 2021, titled "Morepen gets US FDA Approval for Fexofinadine (Allegra) Expected to start export in Q4 FY22".
Morepen Laboratories Limited has informed the Exchange regarding a press release dated December 03, 2021, titled "Morepen gets US FDA Approval for Fexofinadine (Allegra) Expected to start export in Q4 FY22".